Compare $ALLO vs $ASMB | Chartloom

Compare

$ALLO vs $ASMB

Allogene Therapeutics Inc · Assembly Biosciences Inc

ALLO

Allogene Therapeutics Inc

ASMB

Assembly Biosciences Inc

Compare $ALLO vs $ASMB

Comparing Allogene Therapeutics Inc and Assembly Biosciences Inc

ALLOAllogene Therapeutics Inc

ASMBAssembly Biosciences Inc

ALLOAllogene Therapeutics Inc

Market cap

$504M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

39,713.68x

Rev growth (TTM)

—

YTD performance

8.1%

52W performance

-0.7%

FCF yield

-20.4%

ASMBAssembly Biosciences Inc

Market cap

$466M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

17.93x

Rev growth (TTM)

125.1%

YTD performance

-30.3%

52W performance

-7.7%

FCF yield

-8.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALLO

ASMB

Detailed metrics comparison

ALLO

Allogene Therapeutics Inc

ASMB

Assembly Biosciences Inc

Market Cap

ALLO$504M

ASMB$466M

Enterprise Value

ALLO$465M

ASMB$434M

Price

ALLO$1.46

ASMB$23.53

P/E Ratio

ALLON/A

ASMBN/A

P/S Ratio

ALLO108.60x

ASMB6.23x

EV/Sales

ALLO100.28x

ASMB5.80x

EV/EBITDA

ALLO0.00x

ASMB0.00x

P/B Ratio

ALLO1.19x

ASMB1.50x

P/FCF Ratio

ALLON/A

ASMBN/A

EV/FCF

ALLO-4.54x

ASMB-11.26x

PEG Ratio

ALLON/A

ASMBN/A

Forward P/E (NTM)

ALLON/A

ASMBN/A

Forward P/S (NTM)

ALLO39,713.68x

ASMB17.93x

Revenue (TTM)

ALLO$5M

ASMB$75M

Revenue Growth (YoY)

ALLON/A

ASMB125.1%

Forward Rev Growth

ALLO219.7%

ASMB2.1%

Gross Margin (TTM)

ALLO0.0%

ASMB0.0%

Operating Margin (TTM)

ALLO0.0%

ASMB0.0%

EBITDA Margin (TTM)

ALLO-2703.1%

ASMB-11.6%

Net Margin (TTM)

ALLO-2648.4%

ASMB-0.1%

FCF Margin (TTM)

ALLO-2211.2%

ASMB-51.5%

Net Income (TTM)

ALLO$-123M

ASMB$-42K

FCF (TTM)

ALLO$-103M

ASMB$-39M

EPS (TTM)

ALLO-$0.37

ASMB-$0.00

ROE (TTM)

ALLO-3531.0%

ASMB-2.0%

ROA (TTM)

ALLO-2622.0%

ASMB-2.0%

ROIC (TTM)

ALLO-3531.0%

ASMB-2.0%

Cash

ALLO$39M

ASMB$32M

Debt

ALLO$0

ASMB$0

Net Cash/Debt

ALLO$39M

ASMB$32M

Current Ratio (TTM)

ALLO10.72x

ASMB13.99x

Quick Ratio (TTM)

ALLO10.55x

ASMB13.70x

Debt/Equity (TTM)

ALLO0.00x

ASMB0.00x

Debt/Assets (TTM)

ALLO0.0%

ASMB0.0%

Interest Coverage (TTM)

ALLON/A

ASMBN/A

Net Debt/EBITDA (TTM)

ALLO0.00x

ASMB0.00x

Beta

ALLO0.75

ASMB1.21

52W Performance

ALLO-0.7%

ASMB-7.7%

YTD Performance

ALLO8.1%

ASMB-30.3%

% from 52W High

ALLO-67.3%

ASMB-40.7%

% from 52W Low

ALLO40.4%

ASMB8.0%

Asset Turnover (TTM)

ALLO0.01x

ASMB0.28x

FCF Yield (TTM)

ALLO-20.4%

ASMB-8.3%

Earnings Yield (TTM)

ALLO-24.4%

ASMB-0.0%

Dividend Yield (TTM)

ALLON/A

ASMBN/A

Rule of 40

ALLO-2,211.2

ASMB73.6

EV/GP/RG

ALLON/A

ASMBN/A

Ticker research

View ALLO research View ASMB research

Metric	ALLO Allogene Therapeutics Inc	ASMB Assembly Biosciences Inc
Market & Valuation
Market Cap	$504M	$466M
Enterprise Value	$465M	$434M
Price	$1.46	$23.53
P/E Ratio	N/A	N/A
P/S Ratio	108.60x	6.23x
EV/Sales	100.28x	5.80x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.50x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.54x	-11.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	39,713.68x	17.93x
Revenue & Growth
Revenue (TTM)	$5M	$75M
Revenue Growth (YoY)	N/A	125.1%
Forward Rev Growth	219.7%	2.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2703.1%	-11.6%
Net Margin (TTM)	-2648.4%	-0.1%
FCF Margin (TTM)	-2211.2%	-51.5%
Net Income (TTM)	$-123M	$-42K
FCF (TTM)	$-103M	$-39M
EPS (TTM)	-$0.37	-$0.00
ROE (TTM)	-3531.0%	-2.0%
ROA (TTM)	-2622.0%	-2.0%
ROIC (TTM)	-3531.0%	-2.0%
Financial Health
Cash	$39M	$32M
Debt	$0	$0
Net Cash/Debt	$39M	$32M
Current Ratio (TTM)	10.72x	13.99x
Quick Ratio (TTM)	10.55x	13.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	1.21
52W Performance	-0.7%	-7.7%
YTD Performance	8.1%	-30.3%
% from 52W High	-67.3%	-40.7%
% from 52W Low	40.4%	8.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.28x
FCF Yield (TTM)	-20.4%	-8.3%
Earnings Yield (TTM)	-24.4%	-0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,211.2	73.6
EV/GP/RG	N/A	N/A
Ticker research	View ALLO research	View ASMB research

Valuation

P/S Ratio

ASMB

6.23x

ALLO

108.60x

EV/FCF

ASMB

-11.26x

ALLO

-4.54x

Growth & revenue

Revenue Growth TTM

ASMB

125.1%

Forward Revenue Growth

ALLO

219.7%

ASMB

2.1%

Profitability & performance

Gross Margin

ALLO

0.0%

ASMB

0.0%

ROE

ASMB

-2.0%

ALLO

-3531.0%

FCF Yield %

ASMB

-8.3%

ALLO

-20.4%

52-Week Performance

ALLO

-0.7%

ASMB

-7.7%

Detailed metrics comparison

ALLO

Allogene Therapeutics Inc

ASMB

Assembly Biosciences Inc

Market Cap

ALLO$504M

ASMB$466M

Enterprise Value

ALLO$465M

ASMB$434M

Price

ALLO$1.46

ASMB$23.53

P/E Ratio

ALLON/A

ASMBN/A

P/S Ratio

ALLO108.60x

ASMB6.23x

EV/Sales

ALLO100.28x

ASMB5.80x

EV/EBITDA

ALLO0.00x

ASMB0.00x

P/B Ratio

ALLO1.19x

ASMB1.50x

P/FCF Ratio

ALLON/A

ASMBN/A

EV/FCF

ALLO-4.54x

ASMB-11.26x

PEG Ratio

ALLON/A

ASMBN/A

Forward P/E (NTM)

ALLON/A

ASMBN/A

Forward P/S (NTM)

ALLO39,713.68x

ASMB17.93x

Revenue (TTM)

ALLO$5M

ASMB$75M

Revenue Growth (YoY)

ALLON/A

ASMB125.1%

Forward Rev Growth

ALLO219.7%

ASMB2.1%

Gross Margin (TTM)

ALLO0.0%

ASMB0.0%

Operating Margin (TTM)

ALLO0.0%

ASMB0.0%

EBITDA Margin (TTM)

ALLO-2703.1%

ASMB-11.6%

Net Margin (TTM)

ALLO-2648.4%

ASMB-0.1%

FCF Margin (TTM)

ALLO-2211.2%

ASMB-51.5%

Net Income (TTM)

ALLO$-123M

ASMB$-42K

FCF (TTM)

ALLO$-103M

ASMB$-39M

EPS (TTM)

ALLO-$0.37

ASMB-$0.00

ROE (TTM)

ALLO-3531.0%

ASMB-2.0%

ROA (TTM)

ALLO-2622.0%

ASMB-2.0%

ROIC (TTM)

ALLO-3531.0%

ASMB-2.0%

Cash

ALLO$39M

ASMB$32M

Debt

ALLO$0

ASMB$0

Net Cash/Debt

ALLO$39M

ASMB$32M

Current Ratio (TTM)

ALLO10.72x

ASMB13.99x

Quick Ratio (TTM)

ALLO10.55x

ASMB13.70x

Debt/Equity (TTM)

ALLO0.00x

ASMB0.00x

Debt/Assets (TTM)

ALLO0.0%

ASMB0.0%

Interest Coverage (TTM)

ALLON/A

ASMBN/A

Net Debt/EBITDA (TTM)

ALLO0.00x

ASMB0.00x

Beta

ALLO0.75

ASMB1.21

52W Performance

ALLO-0.7%

ASMB-7.7%

YTD Performance

ALLO8.1%

ASMB-30.3%

% from 52W High

ALLO-67.3%

ASMB-40.7%

% from 52W Low

ALLO40.4%

ASMB8.0%

Asset Turnover (TTM)

ALLO0.01x

ASMB0.28x

FCF Yield (TTM)

ALLO-20.4%

ASMB-8.3%

Earnings Yield (TTM)

ALLO-24.4%

ASMB-0.0%

Dividend Yield (TTM)

ALLON/A

ASMBN/A

Rule of 40

ALLO-2,211.2

ASMB73.6

EV/GP/RG

ALLON/A

ASMBN/A

Ticker research

View ALLO research View ASMB research

Metric	ALLO Allogene Therapeutics Inc	ASMB Assembly Biosciences Inc
Market & Valuation
Market Cap	$504M	$466M
Enterprise Value	$465M	$434M
Price	$1.46	$23.53
P/E Ratio	N/A	N/A
P/S Ratio	108.60x	6.23x
EV/Sales	100.28x	5.80x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.19x	1.50x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.54x	-11.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	39,713.68x	17.93x
Revenue & Growth
Revenue (TTM)	$5M	$75M
Revenue Growth (YoY)	N/A	125.1%
Forward Rev Growth	219.7%	2.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2703.1%	-11.6%
Net Margin (TTM)	-2648.4%	-0.1%
FCF Margin (TTM)	-2211.2%	-51.5%
Net Income (TTM)	$-123M	$-42K
FCF (TTM)	$-103M	$-39M
EPS (TTM)	-$0.37	-$0.00
ROE (TTM)	-3531.0%	-2.0%
ROA (TTM)	-2622.0%	-2.0%
ROIC (TTM)	-3531.0%	-2.0%
Financial Health
Cash	$39M	$32M
Debt	$0	$0
Net Cash/Debt	$39M	$32M
Current Ratio (TTM)	10.72x	13.99x
Quick Ratio (TTM)	10.55x	13.70x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.75	1.21
52W Performance	-0.7%	-7.7%
YTD Performance	8.1%	-30.3%
% from 52W High	-67.3%	-40.7%
% from 52W Low	40.4%	8.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.28x
FCF Yield (TTM)	-20.4%	-8.3%
Earnings Yield (TTM)	-24.4%	-0.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,211.2	73.6
EV/GP/RG	N/A	N/A
Ticker research	View ALLO research	View ASMB research